Herbalife's third-quarter net sales rose 6% to $1.4 billion, with adjusted EBITDA of $182 million and a 13.5% margin. The company raised its full-year reported net sales growth outlook to 4.9% to 5.9%.
HLF · Herbalife Ltd.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Close
- $15.57
- Open
- $15.92
- Day range
- $15.52–16.19
- 52-week closing range
- $9.22–19.96
- Average volume, 30 days
- 1.6M
- Short interest
- 7.5M · 7.1% of shares · 5.2 days
- Short volume, last session
- 64%
- Last earnings
- Nov 2, 2026
- Latest filing
- 10-Q · Nov 2
- Price history
- Jan 2020 to Nov 2026
Up next
Latest documents
Herbalife reported third-quarter net sales of $1.35 billion, up 6.0%, and adjusted EBITDA of $182.4 million. Year-to-date operating cash flow reached $298.0 million, and a share repurchase program of up to $250 million over three years was authorized.
Herbalife's nine-month net income fell 33.9% to $94.4 million, mainly due to a $94.6 million loss on debt extinguishment, while net sales rose 6.4% to $3,994.2 million.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 5, 2026TL;DR. Herbalife delivered fourth consecutive quarter of net sales growth, beating constant-currency guidance, while narrowing full-year guidance and raising constant-currency adjusted EBITDA midpoint; however, a $94.6M loss on debt extinguishment drove a GAAP net loss of $26.3M and diluted loss per share of $(0.25).
- + Net sales of $1.3B, up 5.4% YoY, at top of guidance; constant-currency growth of 5.8% exceeded guidance by ~80 bps
- + Full-year 2026 adjusted EBITDA constant-currency midpoint raised; range tightened
- + Full-year 2026 net sales guidance range narrowed with midpoint raised
- − Adjusted effective tax rate jumped to 43.2% from 27.7%, a ~$0.14 unfavorable impact to adjusted diluted EPS; full-year adjusted tax rate now ~35%
- − Gross profit margin declined 30 bps YoY to 77.7% on country mix and higher costs
- − FX was a headwind: 40 bps drag on reported net sales, ~$8M drag on adjusted EBITDA, and reported full-year adjusted EBITDA midpoint lowered
- − EMEA net sales declined 3.5% reported / 5.6% constant currency on 12% volume decline
- − China net sales declined 24.5% reported / 29% constant currency on 29% volume decline
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $661.4M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDA at constant currency non-GAAP | $174.4M | Q2 2026 | — |
| Adjusted EBITDA margin non-GAAP | 12.7% | Six Months Ended June 30, 2026 | -6.6% |
|
|
|||
| China contribution margin | $21.2M | the three months ended June 30, 2026 filing | — |
| Credit Agreement EBITDA non-GAAP | $742.3M | Six Months Ended June 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationAdjusted EBITDA $657.6M (non-GAAP)
+$8.5M Interest income
+$25.9M Inventory write-downs
+$44.1M Share-based compensation expenses
+$5.9M Other expenses (income)
= Credit Agreement EBITDA $742M
|
|||
| Inventory write-downs | $3.5M | Q2 2026 | — |
| Net debt non-GAAP | $1.67B | Q2 2026 | — |
| Net income margin | -2% | Six Months Ended June 30, 2026 | — |
| Primary Reporting Segment contribution margin | $543.3M | the three months ended June 30, 2026 filing | — |
| Primary Reporting Segment contribution margin percentage | 42.9% | the three months ended June 30, 2026 filing | — |
| Share-based compensation expenses | $10.4M | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HLF
this stock
Herbalife Ltd.
|
$1.63B | +20.8% | +0.9% | 9.3 | 7.1% |
|
JBS
Jbs N.V.
|
$39.01B | -17.8% | — | — | 1.3% |
|
KHC
Kraft Heinz Co
|
$29.50B | +2.8% | -0.1% | — | 8.7% |
|
GIS
General Mills Inc
|
$18.44B | -25.8% | +4.1% | — | 7.0% |
|
SJM
J M SMUCKER Co
|
$14.02B | +34.2% | +3.7% | — | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 2, 2026
- This year
- 18
Herbalife reported third-quarter net sales of $1.35 billion, up 6.0%, and adjusted EBITDA of $182.4 million. Year-to-date operating cash flow reached $298.0 million, and a share repurchase program of up to $250 million over three years was authorized.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HLF | +2.4% | +13.0% | +30.8% | +19.3% | +20.8% |
| SPY | -5.5% | -6.3% | -5.6% | -5.3% | +5.0% |
| vs SPY | +7.8% | +19.3% | +36.5% | +24.6% | +15.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.